Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Isofol Strengthens Executive Management Team with the Appointment of Roger Tell, MD, PhD, as Chief Scientific Officer and Senior Vice President of Clinical Development

GOTHENBURG, Sweden, November 19, 2018 – Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL), today announced the recruitment of Roger Tell, MD., PhD as Chief Scientific Officer (CSO) and Senior Vice President (SVP) of clinical development. Dr. Tell has more than a decade of experience as a clinical oncologist in addition to holding management and advisory positions at Eli Lilly, AstraZeneca, Merck, Servier and Aprea Therapeutics. As the new chief scientific officer, Dr. Tell will be in charge of scientific research and technical operations at Isofol. Dr. Tell will also be involved

InDex Pharmaceuticals Holding AB (publ) interim report January – September 2018

Directed share issue strengthens the cash position ahead of the CONDUCT resultsPeriod July – September 2018   · Revenues amounted to SEK 0.0 (0.0) million · Operating result amounted to SEK –15.1 (–13.3) million · Result after tax amounted to SEK –15.1 (–13.1) million, corresponding to SEK –0.24 per share (–0.21) before and after dilution · Cash flow from operating activities amounted to SEK –16.1 (–16.6) million Period January –September 2018 · Revenues amounted to SEK 0.1 (0.1) million · Operating result amounted to SEK –59.9 (–50.7) million · Result after tax

BONESUPPORT™ - POSITIVE RESULTS FROM THE CERTiFy STUDY COMPARING CERAMENT®|BONE VOID FILLER WITH AUTOGRAFT

Lund, Sweden, 08.00 CET, 19 November 2018 – BONESUPPORTTM, an emerging leader in orthobiologics for the management of bone voids, today announces positive top-line data from the CERTiFy (CERAMENT® Treatment of Tibia Plateau Fracture defects) study comparing CERAMENT|BVF with autologous iliac bone graft (autograft). BONESUPPORT CEO Emil Billback said:” Successfully completing the ground-breaking CERTiFy study, to demonstrate CERAMENT BVF is non-inferior to autograft in treating tibia plateau fracture defects, is a major milestone for BONESUPPORT. We expect the results from the study to

Tele2 appoints Kim Hagberg to the Leadership Team

Stockholm – Tele2 AB (Tele2) (Nasdaq Stockholm: TEL2 A and TEL2 B) appoints Kim Hagberg as Executive Vice President, Chief Operations and member of the Leadership Team, reporting to Anders Nilsson, President and CEO, effective as of today.Since Tele2 announced the merger with Com Hem in January 2018, Kim Hagberg has played an essential role in planning and managing the large integration processes, encompassing several areas of expertise. In her new role as EVP, Chief Operations, Kim will continue those efforts and make sure the processes of Tele2 and former Com Hem can be harmonized in a

EVRY ASA: Per Hove appointed as new CEO of EVRY ASA

(Fornebu, 19 November 2018) EVRY ASA is pleased to announce that Per Hove (52) has accepted the position as new Group Chief Executive Officer of EVRY. Per Hove replaces Björn Ivroth, who announced his intention to retire from the company on 16 July 2018. EVRY Board of Directors has assessed external and internal candidates in the process to find Ivroth’s successor. Per Hove has been with EVRY since 2015, where he lately has been holding the position as EVP of EVRY Norway. He has more than 20 years of extensive experience from digitalisation and change management in the IT and Software

Redeye: Aspire Global - Strong momentum

Aspire Global beat our expectations in Q3. Both revenues and EBITDA came in well ahead. We believe that the market has underestimated the effects of Aspire Global´s improvement program. It is clear that these improvements have paved the way for the strong underlying growth trend, easily surpassing market growth rates. As a consequence, we have updated our estimates, which results in a new fair value of SEK 62 per share in Base case.  

Share buy-backs in Telia Company during week 46 2018

During the period November 12, 2018 - November 16, 2018, Telia Company AB (publ) (LEI code 213800FSR9RNDUOTXO25) has repurchased in total 5 215 000 own shares (ISIN: SE0000667925). The share buy-backs form part of the SEK 5 billion share buy-back programme that Telia Company announced on April 20, 2018. The share buy-back programme, which runs between April 23, 2018 and March 22, 2019, is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 ("MAR") and the Commission Delegated Regulation (EU) No 2016/1052 (the "Safe Harbour Regulation").During the period

GoldBlue AB (publ) executes a 100 percent guaranteed new issue of shares with preferential rights for existing shareholders

Stockholm, 19 Nov 2018 07:00 CET This press release must not be announced, published or distributed, either directly or indirectly, in or to the United States, Canada, Australia, Hong Kong, Japan, New Zealand, Switzerland, Singapore or South Africa. GoldBlue's Board, based on the authorization of the Annual General Meeting of June 20, 2018, resolved to issue a new issue of shares and warrants with preferential rights for existing shareholders ("new share issue") of approximately SEK 14.2 million before issue costs. In full exercise of the warrants issued with exercise window at

Ahlstrom-Munksjö publishes pro forma financial information related to the acquisition of Expera and Caieiras and additional selected financial information on Expera

AHLSTROM-MUNKSJÖ OYJ, STOCK EXCHANGE RELEASE November 19, 2018 at 08:00 a.m. EET This stock exchange release may not be published or distributed, in whole or in part, directly or indirectly, in or into Australia, Canada, Hong Kong, Japan, South Africa or the United States or any other country where such publication or distribution would violate applicable laws or rules or would require additional documents to be completed or registered or require any measure to be undertaken, in addition to the requirements under Finnish law. For further information, see “Important notice” below.

Skeletal imitation reveals how bones grow atom-by-atom

Researchers from Chalmers University of Technology, Sweden, have discovered how our bones grow at an atomic level, showing how an unstructured mass orders itself into a perfectly arranged bone structure. The discovery offers new insights, which could yield improved new implants, as well as increasing our knowledge of bone diseases such as osteoporosis.The bones in our body grow through several stages, with atoms and molecules joining together, and those bigger groupings joining together in turn. One early stage in the growth process is when calcium phosphate molecules crystallise, which

Students interpret the world through the photo media in a new exhibition in Malmö

On Friday the 23rd of November the group show “Rest Assured in Unknown Places” will open at Galleri Format in Malmö. The exhibition features nine international artists currently studying on the last year of the MFA Programme in Photography at Valand Academy, University of Gothenburg.The presented works are made using various approaches – from archival material and found images, to the creation of a dialogue between the visual and the written. – The title “Rest Assured in Unknown Places” refers to some of the theories we've been learning about during our study process. It reflects the

Report for the period 1 January - 30 September 2018

1 July- 30 September · Consolidated net sales amounted to 7 888 TSEK (15 063) · Net operating income amounted to 276 TSEK (7 611) · Operating profit amounted to -1 617 TSEK (5 995) · Net profit for the period amounted to -8 404 TSEK (491) · Earnings per share before and after dilution effects amounted to -16,81 SEK (0,98) 1 January - 30 September · Consolidated net sales amounted to 29 634 TSEK (47 183) · Net operating income amounted to 7 646 TSEK (20 830) · Operating profit amounted to -16 063 TSEK (14 101) · Net profit for the period amounted to -32 171

NattoPharma Market Update

Q3 revenue increases by more than 60% on a Q by Q comparisonOslo, Norway (19 November 2018) — NattoPharma reports operating revenues for the third quarter of 2018 of NOK 24,6 million, adjusted for non-product related revenue NOK 23,6 million. This represents growth of 61% compared to the third quarter of 2017. During the same period gross margin has developed positively to 45%, up from 42% in Q2, resulting in a year to date gross margin of 43%. all numbers in NOK million Q3 YTD 2018 2017 2018 2017Product Revenue 23,6 14,7 70,8

Ahlstrom-Munksjö announces the terms and conditions of its rights offering

AHLSTROM-MUNKSJÖ OYJ, STOCK EXCHANGE RELEASE November 19, 2018 at 7:50 a.m. EET This stock exchange release may not be published or distributed, in whole or in part, directly or indirectly, in or into Australia, Canada, Hong Kong, Japan, South Africa or the United States or any other country where such publication or distribution would violate applicable laws or rules or would require additional documents to be completed or registered or require any measure to be undertaken, in addition to the requirements under Finnish law. For further information, see “Important notice” below. The

Hyundai Nishat Motor (Private) Limited selects IFS Applications for nationwide rollout in Pakistan

Hyundai Nishat Motor (Private) Limited looks to IFS to enhance efficiencies and operational excellence across its entire distribution value chain, including franchises and third-party dealers IFS , the global enterprise applications company, announces that Hyundai Nishat Motor (Private) Limited will deploy IFS Applications™ 10  featuring robust, best-practice capabilities tailored for the automotive sector.To empower staff and support the company’s long-term vision of becoming

NEW CHAIRMAN AND BOARD MEMBER PROPOSED FOR MUNTERS GROUP

The shareholders represented in Munters Group’s (MTRS) Nomination Committee have proposed Magnus Lindquist to replace Christopher Curtis as Chairman of the Board of Munters Group and Johan Ek to replace Joakim Karlsson as Board member. The election of new Board members is expected to be held at an Extraordinary General Meeting in December 2018.The shareholders represented in the Nomination Committee of Munters Group have proposed that Magnus Lindquist and Johan Ek be elected new Board members. Christopher Curtis, Chairman of the Board, and Joakim Karlsson, board member, will step down.

Update on Acquisition of Additional Atrush Interest

NOVEMBER 18, 2018 – [16:30 ET]  VANCOUVER, BRITISH COLUMBIA - ShaMaran Petroleum Corp. ("ShaMaran" or the "Company") (TSX VENTURE: SNM) (NASDAQ First North: SNM) refers to the agreement announced on June 4, 2018 whereby the Company’s wholly owned subsidiary, General Exploration Partners, Inc. (“GEP”), agreed in a sale and purchase agreement (the “SPA”) with Marathon Oil KDV B.V. (“MOKDV”) ,a wholly owned subsidiary of Marathon Oil Corporation (“Marathon”), to acquire from MOKDV a further 15% working interest in the Atrush Block Production Sharing Contract in the Kurdistan Region of Iraq (

PCI Highlights Impact of Tariffs on Insurance Costs and Consumers at NAIC Meeting

SAN FRANCISCO - The Property Casualty Insurers Association of America (PCI) made a presentation Saturday to the National Association of Insurance Commissioners’ (NAIC) Property and Casualty Insurance (C) Committee on the potential effect of tariffs on auto insurance costs and consumers. “Tariffs on auto parts could have a significant adverse economic impact on consumers, automobile repair providers, business, and insurers,” said David Snyder, PCI vice president, policy, research, and international. “Based on data from the U.S. Bureau of Economic Analysis, PCI estimates that the proposed

Simple color scales lead to failed recruitments, here are the tests that actually work

In September, the book Surrounded by Bad Bosses, the sequel to the bestsellers Surrounded by Idiots and Surrounded by Psychopaths, was released. The books are based on the DISC model, which assumes that all personalities can be placed in one of four color compartments and is used by both companies and authorities to assess jobseekers.  “Both myself and many of my colleagues in the psychology research field are of the firm opinion that the DISC model is as accurate as a horoscope and that it leads to incorrect assessments and recruitments. It is also important to highlight that there are

Obducat requests seventh convertible loan from Blue Ocean

The board of directors of Obducat AB (publ) (“Obducat” or the “Company”) has requested the seventh convertible loan, amounting to SEK 3,000,000, from the investor European High Growth Opportunities Securitization Fund pertaining to the Blue Ocean Investment Group (”Blue Ocean”), in accordance with the financing solution announced by Obducat through a press release on 27 October 2017.The convertible bonds are issued at a price corresponding to 95 percent of the nominal value, which means that Obducat is provided with SEK 2,850,000. Conversion may be requested, in full or in part, by the

FISKARS CORPORATION: ACQUISITION OF OWN SHARES 16.11.2018

Fiskars Corporation  NOTIFICATION 16.11.2018 at 18:30 EEST FISKARS CORPORATION: ACQUISITION OF OWN SHARES 16.11.2018 Date 16.11.2018Exchange transaction BuyShare class FSKRSAmount       1 255 Average price/share 16.5273  EUR  Highest price/share 16.6400 EUR Lowest price/share 16.3500 EUR Total price 20,741.76  EUR  The shares held by Fiskars Corporation on 16.11.2018: FSKRS 294,110  On behalf of Fiskars Corporation Skandinaviska Enskilda Banken AB (Publ) Antti Salakka   Janne Tiihonen

Revenio Group Corporation: SHARE REPURCHASE 16.11.2018

Revenio Group Plc             ANNOUNCEMENT           16.11.2018 SHARE REPURCHASE 16.11.2018 In the Helsinki Stock Exchange Trade date 16.11.2018Bourse trade BUYShare REG1VAmount 4 346 sharesTotal cost 61 005,24 EURAverage price/ share 14,0371 EUR Company now holds a total of 56.213 sharesincluding the shares repurchased on 16.11.2018. On behalf of Revenio Group Plc. Nordea Bank OyjJanne Sarvikivi         Ilari Isomäki Further information: Timo Hildén, CEO,tel.  +358 40 580 4774

Correction: Carlsberg selects Zalaris to deliver HR and payroll services for their operations in Denmark, Sweden and Norway

With reference to the announcement published on 14 November 2018, please see below for updated announcement on the agreement:Zalaris ASA are humble and honored to sign a contract with Carlsberg Group, the third largest brewery on a global basis. The agreement will include operations for approx. 5 000 employees in Denmark, Sweden and Norway.Carlsberg Group has chosen Zalaris to deliver a wide range of transactional system and HR services, including integration between employee central and payroll.Carlsberg Group is one of the leading brewery groups in the world today, with a large

CORRECTION: Deflamo AB: Interim report third quarter

This is a correction of the announcement from 07:42 16.11.2018 CET. Reason for the correction: The announcement was missing MD Fredrik Westin contact information and name of Certified Advoser.  This Report is only published in Swedish. For further information, contact: Fredrik Westin, MD Tel: +46 (0)70 418 49 59 E-mail: fredrik.westin@deflamo.com   Read more about Deflamo AB: www.deflamo.com Company is listed on Nasdaq First North. Mangold Fondkommission AB, phone +46 8 5030 1550, is Certified Adviser."

There are no items matching the current filter
There are no more items matching the current filter
Back to top